Research News

Similar quit rates are found with three smoking cessation options

BMJ 2016; 352 doi: http://dx.doi.org/10.1136/bmj.i449 (Published 27 January 2016) Cite this as: BMJ 2016;352:i449
  1. Jacqui Wise
  1. 1London

The drug varenicline (Champix) was found to be no better than combination nicotine replacement therapy or a standard nicotine patch in helping adults to stop smoking in the long term, a randomised controlled trial published in JAMA has shown.1

The researchers said that their open label study was the first to contrast varenicline and combination nicotine replacement therapies directly, both with one another and with the nicotine patch. Such a comparison …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe